by Long Island Attorney Paul A. Lauto, Esq. In July 2013 a class action was filed against biotechnology company Biovest International, Inc. (Hill v. Accentia Biopharmaceuticals, Inc. et al.).  The lawsuit emanated from alleged false and misleading statements made by defendant, relative to the success of a developmental vaccine to treat non-Hodgkin’s lymphoma and the … Continue reading Class Action Suit Over Potential Cancer Vaccine Settles For 1.25 Million